P John Byrne's most recent trade in Corebridge Financial Inc. was a trade of 1,995 Common Stock done at an average price of $34.7 . Disclosure was reported to the exchange on March 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Corebridge Financial Inc. | John P Byrne | EVP and PFD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.68 per share. | 03 Mar 2025 | 1,995 | 23,652 | - | 34.7 | 69,187 | Common Stock |
| Corebridge Financial Inc. | John P Byrne | EVP and PFD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 11,390 | 32,267 | - | - | Employee Stock Option (Right to Buy) | |
| Corebridge Financial Inc. | John P Byrne | EVP and PFD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 2,955 | 25,242 | - | 0 | Common Stock | |
| Corebridge Financial Inc. | John P Byrne | Pres of Financial Distributors | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.50 per share. | 04 Mar 2024 | 856 | 22,287 | - | 24.5 | 20,972 | Common Stock |
| Corebridge Financial Inc. | Byrne John P | Pres of Financial Distributors | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 20,877 | 20,877 | - | - | Options (Rights to Buy) | |
| Corebridge Financial Inc. | John P Byrne | Pres of Financial Distributors | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 11,948 | 23,548 | - | 0 | Common Stock | |
| Corebridge Financial Inc. | Byrne P John | Pres of Financial Distributors | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 11,543 | 23,143 | - | 0 | Common Stock | |
| Corebridge Financial Inc. | P John Byrne | Pres of Financial Distributors | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.17 per share. | 17 Jan 2024 | 2,045 | 11,600 | - | 24.2 | 49,428 | Common Stock |
| Avanos Medical Inc | P. John Byrnes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2024 | 8,378 | 49,618 (0%) | 0% | 0 | Common Stock | |
| Avanos Medical Inc | John P. Byrnes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 7,008 | 41,240 (0%) | 0% | 0 | Common Stock | |
| Avanos Medical Inc | John P. Byrnes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 5,354 | 34,232 (0%) | 0% | 0 | Common Stock | |
| Avanos Medical Inc | John P. Byrnes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 4,005 | 28,878 (0%) | 0% | 0 | Common Stock |